...
首页> 外文期刊>Aesthetic plastic surgery >Short-Scar Augmentation Mastopexy in Massive-Weight Loss Patients: Four-Step Surgical Principles for Reliable and Reproducible Results
【24h】

Short-Scar Augmentation Mastopexy in Massive-Weight Loss Patients: Four-Step Surgical Principles for Reliable and Reproducible Results

机译:大规模减肥患者的短瘢痕增强乳腺激素:四步外科原则可靠和可重复的结果

获取原文
获取原文并翻译 | 示例

摘要

Background Single-stage augmentation mastopexy is considered a challenging procedure, and its safety and efficacy remain controversial for breasts with grade-2 and grade-3 ptosis. In this paper, we report our experience in single-stage augmentation mastopexy with implants, using a short-scar technique, outlining the four-step principles of our technique which maximizes the cosmetic outcomes though being safe, reliable and reproducible. Patients and Methods Forty consecutive massive-weight loss (MWL) patients undergoing short-scar augmentation mastopexy with implants between September 2010 and August 2018 were retrospectively analysed. The preoperative evaluation and our four-step surgical principles are presented in detail. Breast shape analysis was performed separately by a blinded group of plastic surgeons and by the attending surgeon using a standardized evaluation method. Breast-Q was used to evaluate patients' satisfaction. Results Patients' average age was 43 (range from 29 to 54). Among the 40 patients, 2 patients were rated as grade 1 (5%), 21 cases (52.5%) grade 2 and 17 (42.5%) grade 3 according to Pittsburgh Rating Scale. The average follow-up time was 40 months (ranging from 3 to 96 months). No major postoperative complications were experienced. Patients' satisfaction was high to very high. Conclusions Augmentation mastopexy with implant in the MWL population remains a challenging procedure, especially in Pittsburgh grade-3 breasts. A bilamellar approach using proper footprint reconstruction allows for very satisfying cosmetic results using the short-scar mastopexy pattern with a very low complication rate. Our four-step surgical principles are provided, which may aid in the surgical planning and execution of such demanding cases. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
机译:背景技术单级增强乳腺被认为是一个具有挑战性的程序,其安全性和疗效仍然对患有2级和3级皮下的乳房造成争议。在本文中,我们在使用短瘢痕技术中向植入物中的单级增强乳房中的经验报告了我们的植入物,概述了我们技术的四步原理,最大化了化妆品结果,尽管安全,可靠和可重复。回顾分析了2010年9月至2018年9月间植入物的短瘢痕增强乳腺癌患者的患者和方法四十连续的大量减肥(MWL)患者。术前评估和我们的四步外科原则详细介绍。通过使用标准化评估方法,通过蒙蔽塑形外科医生和参加外科医生分开进行乳房形状分析。乳房Q用于评估患者的满意度。结果患者的平均年龄为43(范围为29至54)。根据匹兹堡评级规模,在40例患者中,2例患者被评为1级(5%),21例(52.5%)2级和1级(42.5%)3级。平均随访时间为40个月(从3到96个月的范围)。没有经历过主要的术后并发症。患者的满意度高到很高。结论在MWL人口中植入的增强乳房均仍然是一个具有挑战性的程序,尤其是匹兹堡级-3乳房。使用适当的占地面积的毕明素方法允许使用具有非常低并发症率的短疤痕乳房模式非常满足化妆品结果。提供了我们的四步外科原则,可以帮助这种苛刻的病例的手术规划和执行。证据IV级别本期刊要求提交人向每篇文章分配一定程度的证据。有关这些基于证据的药物评级的完整描述,请参阅内容表或在线指示给作者www.springer.com/00266。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号